Palatin Technologies
PTN
#10042
Rank
A$41.94 M
Marketcap
A$24.63
Share price
17.27%
Change (1 day)
1,792.01%
Change (1 year)

Earnings for Palatin Technologies (PTN)

Earnings in 2025 (TTM): -A$7.94 Million

According to Palatin Technologies's latest financial reports the company's current earnings are A$8.84 Million. In 2024 the company made an earning of -A$38.47 Million, an increase over its 2023 earnings that were of -A$46.3 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Palatin Technologies from 1998 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$7.94 Million-79.38%
2024 -A$38.47 Million-16.9%
2023 -A$46.3 Million5.99%
2022 -A$43.68 Million-13.7%
2021 -A$50.62 Million33.25%
2020 -A$37.99 Million-172.11%
2019 A$52.67 M2352.33%
2018 A$2.14 M-94.13%
2017 A$36.59 M-154.92%
2016 -A$66.64 Million3.67%
2015 -A$64.29 Million878%
2014 -A$6.58 Million-72.64%
2013 -A$24.03 Million-33.11%
2012 -A$35.92 Million77.71%
2011 -A$20.21 Million
2003 -A$34.22 Million29.93%
2002 -A$26.34 Million36.18%
2001 -A$19.34 Million
1999 -A$16.06 Million6.04%
1998 -A$15.14 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$46.26 B-675,709.17%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$18.69 B-273,088.15%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
A$0.83 B-12,262.47%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-A$17.15 Million 150.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
A$95.38 M-1,492.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-A$0.17 Billion 2,353.60%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
A$72.19 M-1,154.21%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
-A$42.11 Million 514.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
-A$79.34 Million 1,058.48%๐Ÿ‡บ๐Ÿ‡ธ USA